Anatole Harrois

TL;DR: Patients >65 yrs with underlying chronic cardiac or respiratory disease are at high risk for extubation failure and subsequent pneumonia and death, suggesting a direct and specific effect of extubations failure and reintubation on patient outcomes.

TL;DR: In a prospective uncontrolled cohort study, survivors of COVID-19 who had been hospitalized in a university hospital in France between March 1 and May 29, 2020, underwent a telephone assessment 4 months after discharge, between July 15 and September 18, 2020 as mentioned in this paper.

TL;DR: Anakinra did not improve outcomes in patients with mild-to-moderate COVID-19 pneumonia, and further studies are needed to assess the efficacy of anakinra in other selected groups of patients with more severe CO VID-19.

TL;DR: To move forward, optimal therapeutic approaches with clear objectives for fluid resuscitation, blood pressure, and hemoglobin levels to guide resuscitation and limit the risk of fluid overload and transfusion are needed.

TL;DR: Restoring pulsatility and decreasing left ventricular afterload with intra-aortic balloon pump was associated with smallerleft ventricular dimensions and lower pulmonary artery pressures but did not affect microcirculation variables in cardiogenic shock patients with little/no residual left vent cardiac ejection while on peripheral venoarterial extracorporeal membrane oxygenation.